Hugh MacNaught
Chief Executive Officer at VENTRIPOINT DIAGNOSTICS LTD.
Net worth: 10 020 $ as of 30/05/2024
Network origin in Hugh MacNaught first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Medical Specialties | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Hugh MacNaught via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| DXI CAPITAL CORP. | Oil & Gas Production | Chief Executive Officer | |
| Hemo-Stat Ltd. | President | ||
| McGill University | College/University | Undergraduate Degree | |
Centre For Imaging Technology Commercialization
 Centre For Imaging Technology Commercialization Packaged SoftwareTechnology Services Centre For Imaging Technology Commercialization medical technology manufacturer. The company is headquartered in London, Canada. | Packaged Software | Director/Board Member | |
Cell MedX (Canada) Corp.
 Cell MedX (Canada) Corp. Pharmaceuticals: MajorHealth Technology Part of Cell MedX Corp., Cell MedX (Canada) Corp. is a Canadian pharmaceutical company. The company is based in Vancouver, Canada. The CEO of the company is Frank E. Mcenulty. | Pharmaceuticals: Major | Director/Board Member | |
| CELL MEDX CORP. | Medical Specialties | Chairman | |
| BOSTON SCIENTIFIC CORPORATION | Medical Specialties | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Corvita Corp.
 Corvita Corp. Medical SpecialtiesHealth Technology Corvita Corporation is a development stage company engaged primarily in research and development of new medical devices and related biomaterials for treatment of late stage vascular disease. The company is sponsoring two FDA controlled, randomized prospective trials in the US for its peripheral grafts and AV access grafts, both of which are approved for sale in the European Common Market. In addition, Corvita is conducting clinical tests in Europe and plans to begin FDA controlled clinical studies in the US of the Corvita Endoluminal Graft, a new less invasive product for lower cost treatment of vascular trauma, vascular occlusive disease and aneurysmal disease. The majority of the company's activities in FY 96 will be focused on development and testing of Corvita Endoluminal Grafts. | Medical Specialties | Corporate Officer/Principal | |
| E I DU PONT DE NEMOURS AND CO | Chemicals: Agricultural | Corporate Officer/Principal | |
World Heart Corp.
 World Heart Corp. Miscellaneous Commercial ServicesCommercial Services World Heart Corp. develops artificial heart and related technologies. The company was founded on April 1, 1996 and is headquartered in Salt Lake City, UT. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Baxter Corp.
 Baxter Corp. Medical SpecialtiesHealth Technology Baxter Corp. supplies health care and laboratory products. Its products are used for treating cancer, hemophilia, immune deficiencies, kidney disease, and trauma. The company is headquartered in Mississauga, Canada | Medical Specialties | Corporate Officer/Principal | |
The Canadian Red Cross Society
 The Canadian Red Cross Society Miscellaneous Commercial ServicesCommercial Services The Canadian Red Cross Society offers courses in first aid, CPR, and swimming and water safety. The organization is based in Mississauga, Canada. The Canadian company also provides various services to migrants and refugees upon their arrival. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The University of Ottawa Heart Institute
 The University of Ottawa Heart Institute Hospital/Nursing ManagementHealth Services The University of Ottawa Heart Institute operates as a health center to understand, treat, and prevent heart disease. The firm's clinical departments include clinical care, cardiology, cardiac imaging, cardiac surgery, cardiac anesthesiology, cardiac prevention and rehabilitation, clinical services, biomedical engineering and diagnostic services. The company was founded in 1976 and is headquartered in Ottawa, Canada. | Hospital/Nursing Management | Director/Board Member | |
| PROMIS NEUROSCIENCES, INC. | Biotechnology | Chief Executive Officer | |
| Canadian Biomaterials Society | President | ||
Titan Uranium, Inc.
 Titan Uranium, Inc. Other Metals/MineralsNon-Energy Minerals Titan Uranium, Inc. provides exploration and mining services of uranium. The company was founded by Arni Thomas Werbes on January 29, 1999 and is headquartered in Toronto, Canada. | Other Metals/Minerals | Director/Board Member | |
| Hodgkinson Equities Corp. | Founder | ||
Canaccord Capital Corp.
 Canaccord Capital Corp. Investment ManagersFinance Part of Canaccord Genuity Group, Inc., Canaccord Capital Corp. provides investment advice. The company is based in Vancouver, Canada. | Investment Managers | Corporate Officer/Principal | |
| LITHIUM X ENERGY CORP | Financial Conglomerates | Chairman | |
Dejour Energy (Alberta) Ltd.
 Dejour Energy (Alberta) Ltd. Contract DrillingIndustrial Services Dejour Energy (Alberta) Ltd. engages in the exploration of oil and gas wells. The company was founded on April 5, 2006 and is headquartered in Calgary, Canada. | Contract Drilling | Chief Executive Officer | |
| The University of Waterloo | College/University | Graduate Degree | |
Dejour Energy (USA) Corp.
 Dejour Energy (USA) Corp. Oil & Gas ProductionEnergy Minerals Part of DXI Capital Corp., Dejour Energy (USA) Corp. operates as an oil and natural gas exploration and production company. The company is based in Denver, CO. | Oil & Gas Production | President | |
Exact Imaging, Inc.
 Exact Imaging, Inc. Medical SpecialtiesHealth Technology Exact Imaging, Inc. provides high resolution micro-ultrasound systems enabling real-time imaging and guided biopsies in the urological market for prostate cancer. Its ExactVu micro-ultrasound platform operates at 29 MHz and enables a whole new level of resolution with the benefits of ease of use, affordability, and being an extension of the current urological workflow. The company was founded by Sam Ifergan and Randy AuCoin in 2013 and is headquartered in Markham, Canada. | Medical Specialties | Founder | |
| SERNOVA CORP. | Biotechnology | Chairman | |
| McMaster University | College/University | Doctorate Degree | |
| Concordia University | College/University | Doctorate Degree |
Statistics
International
| Canada | 27 |
| United States | 8 |
| Australia | 2 |
Sectoral
| Health Technology | 11 |
| Consumer Services | 5 |
| Energy Minerals | 4 |
| Commercial Services | 4 |
| Technology Services | 3 |
Operational
| Director/Board Member | 16 |
| President | 13 |
| Corporate Officer/Principal | 10 |
| Chairman | 8 |
| Chief Executive Officer | 7 |
Most connected contacts
| Insiders | |
|---|---|
| George Adams | 18 |
| Robert Hodgkinson | 12 |
| Randy AuCoin | 4 |
| Alvira Macanovic | 3 |
| Fiona Fitzgerald | 2 |
- Stock Market
- Insiders
- Hugh MacNaught
- Company connections
